Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Phase IIb trial of Nefecon for primary IgA nephropathy meets primary endpoint

April 14, 2015

Hydra Biosciences and Boehringer Ingelheim collaborate on TRP inhibitors for renal diseases

April 14, 2015

New Drosophila model of nephrolithiasis presented

April 10, 2015

sGC activators prevent progression of diabetic nephropathy

April 8, 2015

Thrasos Therapeutics secures funds to complete phase II study of THR-184

April 2, 2015

Toray describes highly potent alpha1L-adrenoceptor agonists

March 30, 2015

Università degli Studi di Padova describes use of SERPINB3 for SLE

March 26, 2015

Regulus receives European orphan medicinal product designation for RG-012

March 26, 2015

New solifenacin succinate oral formulation for pediatric use

March 25, 2015

EAU Madrid: Long-term results from the everolimus EXIST-2 trial

March 24, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...